NCT03233646 - Retinal Imaging in Neurodegenerative Disease | Biotech Hunter

Enrollment

2,000

Participants

Timeline

Start Date

July 20, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Alzheimer's DiseaseMild Cognitive ImpairmentParkinson's DiseaseMultiple SclerosisHuntington DiseaseLewy Body DementiaFrontotemporal DementiaAmyotrophic Lateral Sclerosis (ALS)APOE-4 PositiveTraumatic Brain InjuryConcussionPost-Traumatic Stress DisorderDown SyndromeNeuro-Degenerative DiseaseNormal Cognition

Interventions

DEVICE

Retinal and Choroidal Imaging

Non-invasive OCT, OCTA, and UWF fundus photography of retina

Trial Locations (1)

27705

RECRUITING

Duke University Medical Center, Durham